Items tagged with Treatment
End DR-TB patients’ deadly waiting game now, MSF tells SA health authorities (post with simple image)
South Africa could realise savings of up to 42% through fully decentralised models of care, but fragmented, slow government response sees policy stutter after 3 years; MSF negotiates to expand access to effective drugs for more patients at lower price.
South Africa: Litigation threat may prompt access to cheaper DR-TB drug (post with simple image)
South Africa may finally allow access to a cheaper form of the drug-resistant tuberculosis (DR-TB) drug linezolid following the lodging of a high court case.
TB: A dire struggle to keep up on path of increased resistance (post with simple image)
There was recently a small celebration in one of the primary healthcare clinics in Khayelitsha near Cape Town. One more person was officially declared cured after more than two years of treatment for pre-XDR-TB.
South Africa: More MSF patients with DR-TB gain access to dramatically cheaper version of life-saving drug (post with simple image)
Patients & MSF doctors elated as MCC approval for Médecins Sans Frontières to use generic linezolid paves the way for national registration and access.
For patients waiting for XDR-TB treatment in Romania, someday never comes (post with simple image)
For Romanians with XDR-TB, except for the lucky few who get on a bus or a plane and become medical refugees, throwing themselves at the mercy of other European countries, someday never comes.
Meet the 23-year-old TB survivor taking on South Africa's patent laws (post with simple image)
My name is Phumeza Tisile, I am 23-years-old and live in Cape Town. In 2010, I was diagnosed with tuberculosis and was forced to stop my studies at Cape Peninsula University of Technology to go for treatment. Despite this my condition did not improve, and after about five months of treatment, first for "normal" TB and then for multi-drug-resistant TB (MDR-TB), I was finally diagnosed with extensively drug-resistant TB (XDR-TB), the deadliest form of the disease.
The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: a perspective from tuberculosis-affected communities (post with simple image)
Community voices on bedaquiline's use to treat drug-resistant tuberculosis and future development as a potential treatment for drug-susceptible disease have been largely unheard.
Swaziland: Surviving drug-resistant TB: “I’m still over the moon” (post with simple image)
Ninety-nine patients in Swaziland who successfully completed their treatment for drug-resistant tuberculosis have been presented with certificates by Médecins Sans Frontières (MSF) saying “I got tested and cured of TB”.
Reduced treatment delays for people with drug-resistant TB and HIV co-infection through decentralised care and rapid Xpert MTB/RIF test (post with simple image)
Decentralisation of drug-resistant tuberculosis (DR-TB) management and use of the Xpert MTB/RIF test improves the time from clinic presentation to treatment from 50 days to 7 days in a population with a high burden of HIV and TB co-infection, according to a study from Khayelitsha, South Africa, presented at the 20th International AIDS Conference (AIDS 2014) on Monday.
New TB drug bedaquiline: Weighing the benefits against the risks (post with simple image)
Laia Ruiz Mingote and Dorothy Namutamba—co-chairs of CRAG— and Mike Watson Frick—TB/HIV Program Officer at Treatment Action Group—discuss the benefits and risks of using bedaquiline to treat TB.
Page 50 of 60 · Total posts: 0←First 49 50 51 Last→